All TreatGx users now have access to the updated treatment algorithms for Depression, Heart Failure – Fluid Retention, Chronic Pain – Trigeminal Neuralgia, and Hyperlipidemia. Depression In light of its recent approval in Canada and the US, esketamine nasal spray (Spravato) has been added to the Depression Augmentation/Adjunctive therapy options. Highlights include: Approved by Health Canada for…
Please proceed with registration and ordering once you have received your approval letter and promotional code from GSC.